The Discounted Cash Flow (DCF) valuation of Lotus Pharmaceuticals Inc (LTUS) is 5.55 USD. With the latest stock price at 0.00 USD, the upside of Lotus Pharmaceuticals Inc based on DCF is 154101.2%.
Based on the latest price of 0.00 USD and our DCF valuation, Lotus Pharmaceuticals Inc (LTUS) is a buy. buying LTUS stocks now will result in a potential gain of 154101.2%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 6.0% | 5.4% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 4.56 - 7.15 | 5.55 |
| Upside | 126435.3% - 198489.8% | 154101.2% |